Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Premature Infant
Open-data reference.
10 US clinical trials · 3 currently recruiting
Active & Recent Trials
Growing Little PEAPODS Study
University of Wisconsin, Madison
NCT06226051
Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
University of Texas Southwestern Medical Center
NCT03906435
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
University of Colorado, Denver
NCT03797183
Cycled Phototherapy
NICHD Neonatal Research Network
NCT03927833
Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)
Children's Hospital Medical Center, Cincinnati
NCT03345069
Ultrasound Assessment of BC in the NICU
University of Minnesota
NCT03241082
Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.
University of Florida
NCT03277768
Time to Accurate Heart Rate on Neonatal Outcomes
Sharp HealthCare
NCT04587934
Work of Breathing and Kangaroo Mother Care
Christiana Care Health Services
NCT03683316
Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida
Joseph Bliss
NCT03630770
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Premature Infant Trial Landscape
ClinicalTrials.gov lists 10 US studies indexed under Premature Infant, and 3 of those are currently open to recruitment — roughly 30% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Premature Infant shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 1 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Premature Infant is led by Joseph Bliss with 1 indexed trial, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 10 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Premature Infant?
PlainTrial tracks 10 US clinical trials for Premature Infant, of which 3 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Premature Infant?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.